In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OraPharma, Inc.

http://www.orapharma.com/

Latest From OraPharma, Inc.

Deals Shaping The Medical Industry, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June-August 2014.

BioPharmaceutical Medical Device

Valeant OTC Strategy Leverages “Relationships With Doctors”

The Canadian specialty pharma firm plans to continue bolt-on acquisitions in 2014, including more OTC products that are doctor recommended, executives say.

Consumer BioPharmaceutical

Valeant OTC Strategy Leverages “Relationships With Doctors”

The Canadian specialty pharma firm plans to continue bolt-on acquisitions in 2014, including more OTC products that are doctor recommended, executives say.

Consumer BioPharmaceutical

Acquisitive Valeant Sheds Staff As It Closes Bausch & Lomb Deal

The fast-growing, Canadian specialty pharma will shed thousands of jobs as it absorbs Bausch & Lomb, as part of an endeavor to save $800 million. CEO Mike Pearson’s note to employees describes a new organizational philosophy, with restructured management and business units.

BioPharmaceutical United States
See All

Company Information

UsernamePublicRestriction

Register